Bank of America downgraded shares of HCA Healthcare (NYSE:HCA) from a neutral rating to an underperform rating in a research note issued to investors on Thursday. Bank of America currently has $90.00 price objective on the stock, down from their previous price objective of $94.00.

Other equities research analysts have also recently issued research reports about the company. Cantor Fitzgerald reaffirmed a buy rating and set a $95.00 target price on shares of HCA Healthcare in a research note on Wednesday, September 6th. SunTrust Banks set a $90.00 target price on HCA Healthcare and gave the stock a buy rating in a research note on Sunday, October 15th. Jefferies Group reissued a buy rating and issued a $92.00 price objective on shares of HCA Healthcare in a research note on Friday, October 13th. Mizuho reissued a buy rating and issued a $92.00 price objective on shares of HCA Healthcare in a research note on Wednesday, October 4th. Finally, Piper Jaffray Companies reissued a buy rating and issued a $92.00 price objective on shares of HCA Healthcare in a research note on Wednesday, October 4th. Three analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have assigned a buy rating to the company. The company presently has a consensus rating of Buy and an average target price of $87.60.

HCA Healthcare (NYSE HCA) traded down $0.18 during midday trading on Thursday, reaching $86.75. The company had a trading volume of 1,367,429 shares, compared to its average volume of 2,285,120. HCA Healthcare has a fifty-two week low of $71.18 and a fifty-two week high of $91.03. The firm has a market capitalization of $31,340.00, a PE ratio of 12.34, a P/E/G ratio of 1.17 and a beta of 0.55. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 31st. The company reported $1.21 EPS for the quarter, hitting the consensus estimate of $1.21. HCA Healthcare had a negative return on equity of 47.16% and a net margin of 6.13%. The business had revenue of $10.70 billion during the quarter, compared to analysts’ expectations of $10.70 billion. During the same quarter last year, the firm posted $1.45 earnings per share. The firm’s revenue was up 4.1% on a year-over-year basis. sell-side analysts predict that HCA Healthcare will post 6.56 earnings per share for the current year.

In related news, SVP Victor L. Campbell sold 8,000 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $75.82, for a total transaction of $606,560.00. Following the transaction, the senior vice president now owns 127,275 shares of the company’s stock, valued at $9,649,990.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michael S. Cuffe sold 2,150 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the transaction, the insider now directly owns 12,476 shares in the company, valued at approximately $973,128. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 22,700 shares of company stock worth $1,773,872. 2.90% of the stock is owned by insiders.

Large investors have recently made changes to their positions in the stock. AustralianSuper Pty Ltd bought a new stake in HCA Healthcare during the third quarter worth $24,410,000. Parametric Portfolio Associates LLC lifted its holdings in HCA Healthcare by 4.2% during the third quarter. Parametric Portfolio Associates LLC now owns 1,346,771 shares of the company’s stock worth $107,190,000 after acquiring an additional 54,653 shares during the period. IFM Investors Pty Ltd bought a new stake in HCA Healthcare during the third quarter worth $646,000. Yellowstone Partners LLC bought a new stake in HCA Healthcare during the third quarter worth $5,802,000. Finally, Neuberger Berman Group LLC lifted its holdings in HCA Healthcare by 10.7% during the third quarter. Neuberger Berman Group LLC now owns 1,820,685 shares of the company’s stock worth $144,908,000 after acquiring an additional 176,494 shares during the period. 75.34% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Bank of America Lowers HCA Healthcare (HCA) to Underperform” was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.watchlistnews.com/bank-of-america-lowers-hca-healthcare-hca-to-underperform/1798867.html.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.